AV nodal re-entrant tachycardia (AVNRT)
Regular narrow-complex SVT · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Abrupt-onset regular narrow-complex tachycardia (typically 150-250/min) from re-entry within the AV node; the commonest paroxysmal SVT.
Red flags
- Haemodynamic instability
- Ischaemic chest pain or ST changes
- Syncope
- Wide QRS raising pre-excitation
Assessment
Differential diagnosis
- Atrial flutter with 2:1 block
- Focal atrial tachycardia
- Orthodromic AVRT
- Sinus tachycardia
- Junctional tachycardia
Investigations
- 12-lead ECG (pseudo-R in V1, retrograde P waves)
- Continuous rhythm monitoring
- Electrolytes, magnesium and TFTs
- Troponin if chest pain
Management
- Confirm regular narrow QRS and assess haemodynamic status
- Trial vagal manoeuvres (modified Valsalva) with monitoring
- If persists give adenosine 6 mg rapid IV, then 12 mg if needed
- If unstable perform synchronised DC cardioversion
- If adenosine fails and stable use a rate-limiting CCB or beta-blocker
- Refer for electrophysiology study and ablation
Drugs & doses
Adenosine (antiarrhythmic) - 6 mg rapid IV push, repeat 12 mg
Verapamil (CCB) - 2.5-5 mg slow IV if stable and definitely narrow QRS
Metoprolol (beta-blocker) - IV/oral rate control
Disposition
Discharge after reversion with EP referral; admit if unstable or structural heart disease.
Complications & pitfalls
- Recurrence
- Tachycardia-induced cardiomyopathy if incessant
- Transient asystole or bronchospasm with adenosine
Exam pearls
- Record a continuous strip across adenosine administration
- Avoid adenosine in severe asthma
- Modified Valsalva (leg lift) improves reversion rates
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.